BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 26732762)

  • 21. A role for NBR1 in autophagosomal degradation of ubiquitinated substrates.
    Kirkin V; Lamark T; Sou YS; Bjørkøy G; Nunn JL; Bruun JA; Shvets E; McEwan DG; Clausen TH; Wild P; Bilusic I; Theurillat JP; Øvervatn A; Ishii T; Elazar Z; Komatsu M; Dikic I; Johansen T
    Mol Cell; 2009 Feb; 33(4):505-16. PubMed ID: 19250911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequestosome 1/p62 links familial ALS mutant SOD1 to LC3 via an ubiquitin-independent mechanism.
    Gal J; Ström AL; Kwinter DM; Kilty R; Zhang J; Shi P; Fu W; Wooten MW; Zhu H
    J Neurochem; 2009 Nov; 111(4):1062-73. PubMed ID: 19765191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamics of the degradation of ubiquitinated proteins by proteasomes and autophagy: association with sequestosome 1/p62.
    Myeku N; Figueiredo-Pereira ME
    J Biol Chem; 2011 Jun; 286(25):22426-40. PubMed ID: 21536669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The E3-ubiquitin ligase TRIM50 interacts with HDAC6 and p62, and promotes the sequestration and clearance of ubiquitinated proteins into the aggresome.
    Fusco C; Micale L; Egorov M; Monti M; D'Addetta EV; Augello B; Cozzolino F; Calcagnì A; Fontana A; Polishchuk RS; Didelot G; Reymond A; Pucci P; Merla G
    PLoS One; 2012; 7(7):e40440. PubMed ID: 22792322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammasome activation by mitochondrial oxidative stress in macrophages leads to the development of angiotensin II-induced aortic aneurysm.
    Usui F; Shirasuna K; Kimura H; Tatsumi K; Kawashima A; Karasawa T; Yoshimura K; Aoki H; Tsutsui H; Noda T; Sagara J; Taniguchi S; Takahashi M
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):127-36. PubMed ID: 25378412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mst1 participates in the atherosclerosis progression through macrophage autophagy inhibition and macrophage apoptosis enhancement.
    Wang T; Zhang L; Hu J; Duan Y; Zhang M; Lin J; Man W; Pan X; Jiang Z; Zhang G; Gao B; Wang H; Sun D
    J Mol Cell Cardiol; 2016 Sep; 98():108-16. PubMed ID: 27496379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SQSTM1/p62-mediated autophagy compensates for loss of proteasome polyubiquitin recruiting capacity.
    Demishtein A; Fraiberg M; Berko D; Tirosh B; Elazar Z; Navon A
    Autophagy; 2017 Oct; 13(10):1697-1708. PubMed ID: 28792301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. P2X7R is involved in the progression of atherosclerosis by promoting NLRP3 inflammasome activation.
    Peng K; Liu L; Wei D; Lv Y; Wang G; Xiong W; Wang X; Altaf A; Wang L; He D; Wang H; Qu P
    Int J Mol Med; 2015 May; 35(5):1179-88. PubMed ID: 25761252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autophagy suppresses interleukin-1β (IL-1β) signaling by activation of p62 degradation via lysosomal and proteasomal pathways.
    Lee J; Kim HR; Quinley C; Kim J; Gonzalez-Navajas J; Xavier R; Raz E
    J Biol Chem; 2012 Feb; 287(6):4033-40. PubMed ID: 22167182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LC3- and p62-based biochemical methods for the analysis of autophagy progression in mammalian cells.
    Jiang P; Mizushima N
    Methods; 2015 Mar; 75():13-8. PubMed ID: 25484342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HACE1-dependent protein degradation provides cardiac protection in response to haemodynamic stress.
    Zhang L; Chen X; Sharma P; Moon M; Sheftel AD; Dawood F; Nghiem MP; Wu J; Li RK; Gramolini AO; Sorensen PH; Penninger JM; Brumell JH; Liu PP
    Nat Commun; 2014 Mar; 5():3430. PubMed ID: 24614889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autophagy dysfunction and regulatory cystatin C in macrophage death of atherosclerosis.
    Li W; Sultana N; Siraj N; Ward LJ; Pawlik M; Levy E; Jovinge S; Bengtsson E; Yuan XM
    J Cell Mol Med; 2016 Sep; 20(9):1664-72. PubMed ID: 27079462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway.
    Niemi K; Teirilä L; Lappalainen J; Rajamäki K; Baumann MH; Öörni K; Wolff H; Kovanen PT; Matikainen S; Eklund KK
    J Immunol; 2011 Jun; 186(11):6119-28. PubMed ID: 21508263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Caspase-1 autoproteolysis is differentially required for NLRP1b and NLRP3 inflammasome function.
    Guey B; Bodnar M; Manié SN; Tardivel A; Petrilli V
    Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17254-9. PubMed ID: 25404286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TBK1 controls autophagosomal engulfment of polyubiquitinated mitochondria through p62/SQSTM1 phosphorylation.
    Matsumoto G; Shimogori T; Hattori N; Nukina N
    Hum Mol Genet; 2015 Aug; 24(15):4429-42. PubMed ID: 25972374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The roles of p62/SQSTM1 on regulation of matrix metalloproteinase-9 gene expression in response to oxLDL in atherosclerosis.
    Zhou F; Liu D; Ning HF; Yu XC; Guan XR
    Biochem Biophys Res Commun; 2016 Apr; 472(3):451-8. PubMed ID: 26898796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human-IAPP disrupts the autophagy/lysosomal pathway in pancreatic β-cells: protective role of p62-positive cytoplasmic inclusions.
    Rivera JF; Gurlo T; Daval M; Huang CJ; Matveyenko AV; Butler PC; Costes S
    Cell Death Differ; 2011 Mar; 18(3):415-26. PubMed ID: 20814419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploiting macrophage autophagy-lysosomal biogenesis as a therapy for atherosclerosis.
    Sergin I; Evans TD; Zhang X; Bhattacharya S; Stokes CJ; Song E; Ali S; Dehestani B; Holloway KB; Micevych PS; Javaheri A; Crowley JR; Ballabio A; Schilling JD; Epelman S; Weihl CC; Diwan A; Fan D; Zayed MA; Razani B
    Nat Commun; 2017 Jun; 8():15750. PubMed ID: 28589926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperuricemia-induced NLRP3 activation of macrophages contributes to the progression of diabetic nephropathy.
    Kim SM; Lee SH; Kim YG; Kim SY; Seo JW; Choi YW; Kim DJ; Jeong KH; Lee TW; Ihm CG; Won KY; Moon JY
    Am J Physiol Renal Physiol; 2015 May; 308(9):F993-F1003. PubMed ID: 25651569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NF-κB Restricts Inflammasome Activation via Elimination of Damaged Mitochondria.
    Zhong Z; Umemura A; Sanchez-Lopez E; Liang S; Shalapour S; Wong J; He F; Boassa D; Perkins G; Ali SR; McGeough MD; Ellisman MH; Seki E; Gustafsson AB; Hoffman HM; Diaz-Meco MT; Moscat J; Karin M
    Cell; 2016 Feb; 164(5):896-910. PubMed ID: 26919428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.